Overview

Multicentre Biomarker Study in CRPC Treated With Enzalutamide

Status:
Recruiting
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
Prospective Multi-centre Study of Prognostic Factors in Castration Resistant PROState Cancer Treated With Enzalutamide (PROSENZA).
Phase:
N/A
Details
Lead Sponsor:
Centro Nacional de Investigaciones Oncologicas CARLOS III
Collaborator:
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud